Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Opioid Continuing Education Rules Hamper REMS Assessments

This article was originally published in The Pink Sheet Daily

Executive Summary

Sponsors do not have access to list of who completed the courses, so they can't tell if those prescribers changed their behavior.


Related Content

FDA's Opioid REMS Review Puts Brakes On Mandatory Education Push


Related Companies